Mayo Clinic laboratory and pathology research roundup: May 4
Share this:
The research roundup provides an overview of the past week’s research from Mayo Clinic Laboratories consultants, including featured abstracts and a complete list of published studies and reviews.
Featured Abstract
Positive predictive value of myelin oligodendrocyte glycoprotein autoantibody testing.
This diagnostic study was conducted over 2 years, from January 1, 2018, through December 31, 2019. Patients in the Mayo Clinic who were consecutively tested for MOG-IgG1 by live cell-based flow cytometry during their diagnostic workup were included. Patients without research authorization were excluded. Via JAMA Neurology.
Published to PubMed This Week
- Clinical utility of striational antibodies in paraneoplastic and myasthenia gravis paraneoplastic panels.
Neurology - Detection of pathogenic bacteria from septic patients using 16S rRNA gene targeted metagenomic sequencing.
Clinical Infectious Disease - Mutations and thrombosis in essential thrombocythemia.
Blood Cancer Journal - COVID-19 infection in solid organ transplant recipients after SARS-CoV-2 vaccination.
American Journal of Transplant - PD-L1 tumor-intrinsic signaling and its therapeutic implication in triple-negative breast cancer.
JCI Insights - Clinical utility of antiretinal antibody testing.
JAMA Ophthalmology - Young platelet millionaires with essential thrombocythemia.
American Journal of Hematology - Assessment of fixed-duration therapies for treatment-naïve waldenström macroglobulinemia.
American Journal of Hematology - Acute myeloid leukemia after age 70 years: A retrospective comparison of survival following treatment with intensive versus HMA ± venetoclax chemotherapy.
American Journal of Hematology - Clinical, molecular, and prognostic comparisons between CCUS and lower-risk MDS: a study of 187 molecularly annotated patients.
Blood Advances
